In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 1, 1997, Pages 45-51

  Cirioni, Oscar ^a,b   Giacometti, Andrea ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Azienda Ospedaliera Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; DAPSONE; DIAVERIDINE; DIHYDROFOLATE REDUCTASE INHIBITOR; MACROLIDE; PYRIMETHAMINE; ROXITHROMYCIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG SENSITIVITY; NONHUMAN; PNEUMOCYSTIS CARINII;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ATOVAQUONE; CELLS, CULTURED; DAPSONE; DRUG SYNERGISM; FOLIC ACID ANTAGONISTS; HUMANS; LUNG; MACROLIDES; MICROBIAL SENSITIVITY TESTS; NAPHTHOQUINONES; PNEUMOCYSTIS; SULFAMETHOXAZOLE;

EID: 0031043006     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.1.45     Document Type: Article

References (18)

1. Alder, J., Mitten, M., Shipkowitz, N., Hernandez, L., Hui, Y. H., Marsh, K. et al. (1994). Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole. Journal of Antimicrobial Chemotherapy 33, 253-63.
2. Cushion, M. T., Stanforth, D., Linke, M. J. & Walzer, P. D. (1985). Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro. Antimicrobial Agents and Chemotherapy, 28, 796-801.
3. Walzer, P. D., Foy, J., Steele, P. & White, M. (1992). Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs. Antimicrobial Agents and Chemotherapy 36, 1943-50.
4. Queener, S. F. (1991). Inhibition of Pneumocystis dihydrofolate reductase by analogs of pyrimethamine, methotrexate and trimetrexate. Journal of Protozoology 38, 154S-7S.
5. Walzer, P. D., Foy, J., Steele, P. & White, M. (1993). Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis. Antimicrobial Agents and Chemotherapy 37, 1436-43.
6. Dohn, M. N., Frame, P. T., Baughman, R. P., Lafon, S. W., Smulian, A. G., Caldwell, P. et al. (1991). Open-label efficacy and safety trial of 42 days of 566C80 for Pneumocystis carinii pneumonia in AIDS patients. Journal of Protozoology 38, 220S-21S.
7. Hughes, W. T., Jacobus, D. P., Canfield, C. & Killmar, J. (1993). Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist. Antimicrobial Agents and Chemotherapy 37, 1417-9.
8. Ittarat, I., Asawamahasakda, W., Bartlett, M. S., Smith, J. W. & Meshnick, S. R. (1995). Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase. Antimicrobial Agents and Chemotherapy 39, 325-8.
9. Black, J. R., Feinberg, J., Murphy, R. L., Fass, R. J., Carey, J. & Sattler, F. R. (1991). Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS. European Journal of Clinical Microbiology and Infectious Diseases 10, 204-7.
10. Hughes, W. T. (1991). Macrolide-antifol synergism in anti- Pneumocystis carinii therapeutics. Journal of Protozoology 38, 160S.
11. Toma, E., Fournier, S., Dumont, M., Bolduc, P. & Deschamps, H. (1993). Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial. Clinical Infectious Diseases 17, 178-84.
12. Schmatz, D. M., Powles, M. A., McFadden, D. C., Pittarelli, L., Balkovec, J., Hammond, M. et al. (1992). Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats. Antimicrobial Agents and Chemotherapy 36, 1964-70.
13. Atzori, C., Bruno, A., Chichino, G., Bombardelli, E., Scaglia, M. & Ghione, M. (1993). Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii. Antimicrobial Agents and Chemotherapy, 37, 1492-6.
14. Contini, C., Manganaro, M., Romani, R., Tzantzoglou, S., Poggesi, I., Vullo, V. et al. (1994). Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia. Journal of Antimicrobial Chemotherapy 34, 727-35.
15. Cirioni, O., Giacometti, A., Balducci, M., Burzacchini, F. & Scalise, G. (1995). In-vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii Journal of Antimicrobial Chemotherapy 36, 740-2.
16. Allegra, C. J., Boarman, D., Kovacs, J. A., Morrison, P., Beaver, J., Chabner, B. A. et al. (1990). Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase. Journal of Clinical Investigation US, 371-9.
17. Hughes, W. T. & Killmar, J. T. (1991). Synergistic anti-Pneumocystis carinii effects of erythromycin and sulfisoxazole. Journal of Acquired Immune Deficiency Syndromes 4, 532-7.
18. Edman, J. C., Kovacs, J. A., Masur, H., Santi, D. V., Elwood, H. J. & Sogin, M. L. (1988). Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334, 519-22.